345 related items for PubMed ID: 35989868
1. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
Li W, Zhang L, Wang Z, He X, Lin H, Wang Y, Yuan J, Xie X, Zhang X, Qin Y, Huang P.
Int J Clin Pract; 2022; 2022():2726686. PubMed ID: 35989868
[Abstract] [Full Text] [Related]
2. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
Liu J, Ye B, Su D, Qin S, Zhao W, Pang Y.
Clin Rheumatol; 2023 Jan; 42(1):167-177. PubMed ID: 36129563
[Abstract] [Full Text] [Related]
3. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
J Int Med Res; 2024 May; 52(5):3000605241252115. PubMed ID: 38713460
[Abstract] [Full Text] [Related]
4. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
5. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
Eur J Pediatr; 2023 Oct 21; 182(10):4399-4406. PubMed ID: 37480545
[Abstract] [Full Text] [Related]
6. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
[Abstract] [Full Text] [Related]
7. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Sep 27; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
8. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
Ann Med; 2023 Sep 27; 55(2):2264315. PubMed ID: 37870383
[Abstract] [Full Text] [Related]
9. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
Pediatr Infect Dis J; 2018 Oct 27; 37(10):976-980. PubMed ID: 29461447
[Abstract] [Full Text] [Related]
10. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
Cardiovasc Ther; 2021 Oct 27; 2021():6660407. PubMed ID: 34239607
[Abstract] [Full Text] [Related]
11. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
Int J Rheum Dis; 2013 Apr 27; 16(2):168-72. PubMed ID: 23773640
[Abstract] [Full Text] [Related]
12. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E.
Turk J Pediatr; 2020 Apr 27; 62(1):1-9. PubMed ID: 32253860
[Abstract] [Full Text] [Related]
13. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
Zhang R, Shuai S, Zhang H, Cai J, Cui N, Tang M, Xing S, Gao Y, Liu X, Yang X.
Ital J Pediatr; 2023 Jun 25; 49(1):78. PubMed ID: 37357258
[Abstract] [Full Text] [Related]
14. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May 25; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
15. [Association of liver damage with coronary artery lesion and no response to intravenous immunoglobulin in the acute stage of Kawasaki disease].
Hu HM, Chen XZ, Zhang YL, DU ZD.
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jun 15; 24(6):681-686. PubMed ID: 35762436
[Abstract] [Full Text] [Related]
16. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.
Liu X, Wang L, Zhou K, Shao S, Hua Y, Wu M, Liu L, Wang C.
Pediatr Rheumatol Online J; 2021 Mar 12; 19(1):24. PubMed ID: 33712036
[Abstract] [Full Text] [Related]
17. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
Li G, Wang T, Gou Y, Zeng R, Liu D, Duan Y, Liu B.
Int Immunopharmacol; 2020 Dec 12; 89(Pt A):107037. PubMed ID: 33242833
[Abstract] [Full Text] [Related]
18. Risk Factors for Coronary Artery Aneurysm in a Chinese Pediatric Population with Kawasaki Disease at Low Risk of Intravenous Immunoglobulin Resistance: A Retrospective Cohort Study.
Liu J, Su D, Yuan P, Ye B, Qin S, Pang Y.
Cardiology; 2023 Dec 12; 148(5):457-468. PubMed ID: 37231847
[Abstract] [Full Text] [Related]
19. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
PLoS One; 2015 Dec 12; 10(12):e0144603. PubMed ID: 26658843
[Abstract] [Full Text] [Related]
20. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
Li SY, Ding Y.
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar 15; 25(3):244-249. PubMed ID: 36946157
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
